Market feasibility, competitive landscape, and opportunity assessment FDA pathway identification and approval strategy Commercial readiness and go-to-market planning
InsightX derived pathway Development and scale-up strategy aligned with US regulatory expectations Integrated regulatory, CMC, and commercialization planning Decision support across critical development and launch milestone
NDA, ANDA, 505(b)(2), and DMF regulatory pathways Submission planning, regulatory writing, and filing support FDA interaction management, including responses to agency queries
IP landscape assessment and freedom-to-operate analysis Exclusivity and lifecycle management strategies Alignment of regulatory and IP approaches to strengthen long-term protection
Advisory support from experienced pharmaceutical scientists and leaders Troubleshooting complex formulation, development, and scale-up challenges Practical insights grounded in real-world regulatory and commercialization experience
Partners
